BASF shuts ibuprofen production at U.S. plant due to technical problem
FRANKFURT (Reuters) - German chemicals group BASF has shut down production of ibuprofen at its plant in Bishop, Texas because of a technical problem, a spokesman for BASF said on Wednesday.
The spokesman said it could take until early September to fix the problem at the plant, where ibuprofen production has been shut down since June 3.
He gave no further details of the nature of the technical issue, but said a more detailed analysis should be available next month.
It said at the time that the investment would make it the only company worldwide making ibuprofen at more than one plant. The new facility in Germany is scheduled to come online in 2021.